TRLV Share Price Performance
US$0
-4.40 (-100.00%)
Price US$0
Fair ValueUS$19.42
Share Pricen/a
Narrative Update • Jul 16
Trulieve Cannabis Corp. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
TRLV Community Narratives
AN
Fair Value
·Fair Value US$19.42 54.9% undervalued intrinsic discount
Federal Rescheduling And Medical Expansion Will Support A Stronger Long Term Cannabis Operator
1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value US$17.25 49.2% undervalued intrinsic discount
Rescheduling Uncertainty And Texas Execution Risks Will Pressure Results Yet Support Long Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Rescheduling Uncertainty And Texas Execution Risks Will Pressure Results Yet Support Long Term Upside
Trulieve could get a big boost if U.S. rules ease around medical cannabis, but the timing and details are still unclear and may keep results choppy. The next leg of growth depends on how well it executes in newer states like Texas and Georgia while dealing with pricing pressure and tougher consumer spending.Read more
AN
US$17.25
49.2% undervalued intrinsic discount
Fair Value
Profit Margin
33.44%
Future PE
14.15x
Price in 2029
US$21.09
Federal Rescheduling And Medical Expansion Will Support A Stronger Long Term Cannabis Operator
Trulieve could get a real lift if US rules around medical cannabis soften, making it easier to keep more of what it earns and reinvest in stores, products, and customer tech. But the upside leans on policy timing and state-by-state rollouts, and pricing pressure could blunt the benefits if demand doesn’t keep up.Read more
AN
US$19.42
54.9% undervalued intrinsic discount
Fair Value
Profit Margin
37.38%
Future PE
13.73x
Price in 2029
US$23.74
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
TRLV: Georgia Expansion And Schedule III Pathway Will Support Future Upside
Fair Value: US$17.25 49.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
TRLV: NYSE Listing And Buybacks Will Support Future Upside Potential
Fair Value: US$19.42 54.9% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Trulieve Cannabis Corp. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 07, 2026
- -0.40
- 59.65%
- -6.50%
- 25.3%
About TRLV
- Founded
- 1940
- Employees
- 5000
- CEO
- WebsiteView website
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
